scholarly journals Selective androgen receptor modulators: the future of androgen therapy?

2020 ◽  
Vol 9 (S2) ◽  
pp. S135-S148 ◽  
Author(s):  
Andrew R. Christiansen ◽  
Larry I. Lipshultz ◽  
James M. Hotaling ◽  
Alexander W. Pastuszak
F1000Research ◽  
2017 ◽  
Vol 6 ◽  
pp. 68 ◽  
Author(s):  
Arthi Thirumalai ◽  
Kathryn E. Berkseth ◽  
John K. Amory

The treatment of hypogonadism in men is of great interest to both patients and providers. There are a number of testosterone formulations currently available and several additional formulations under development. In addition, there are some lesser-used alternative therapies for the management of male hypogonadism, which may have advantages for certain patient groups. The future of hypogonadism therapy may lie in the development of selective androgen receptor modulators that allow the benefits of androgens whilst minimizing unwanted side effects.


2016 ◽  
Vol 9 (7) ◽  
pp. 1017-1025 ◽  
Author(s):  
Dante Rojas ◽  
Gaud Dervilly-Pinel ◽  
Nora Cesbron ◽  
Mylène Penot ◽  
Alexandre Sydor ◽  
...  

2016 ◽  
Vol 118 (3) ◽  
pp. 640-646 ◽  
Author(s):  
Suriyan Ponnusamy ◽  
Ryan D. Sullivan ◽  
Thirumagal Thiyagarajan ◽  
Heather Tillmann ◽  
Robert H. Getzenberg ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document